{"id":7026,"date":"2022-08-23T09:28:46","date_gmt":"2022-08-23T07:28:46","guid":{"rendered":"https:\/\/value-dossier.com\/?p=7026"},"modified":"2025-09-21T18:52:50","modified_gmt":"2025-09-21T16:52:50","slug":"pharmabarometer-update","status":"publish","type":"post","link":"https:\/\/value-dossier.com\/en\/pharmabarometer-update\/","title":{"rendered":"Pharmabarometer Update"},"content":{"rendered":"\n<section class=\"wrap_outer textblock\">\n    <div class=\"wrap_inner\">\n\n        <div class=\"okd-text\">\n            <p>Have a look at our latest update of German price negotiations for drugs that went through the AMNOG benefit assessment. The mean price decrease after negotiations was 28 % for all analysed products, 23 % for orphan drugs and 30 % for non-orphan drugs.<\/p>\n<p>If you have any further questions or suggestions, please feel free to contact our team of experts.<\/p>\n<div id=\"attachment_6026\" style=\"width: 2570px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-6026\" class=\"wp-image-6026 size-full\" src=\"https:\/\/value-dossier.com\/wp-content\/uploads\/2022\/08\/Pharmabarometer-August-2022-neuer-Titel-2-scaled-1.jpg\" alt=\"\" width=\"2560\" height=\"1901\" srcset=\"https:\/\/value-dossier.com\/wp-content\/uploads\/2022\/08\/Pharmabarometer-August-2022-neuer-Titel-2-scaled-1.jpg 2560w, https:\/\/value-dossier.com\/wp-content\/uploads\/2022\/08\/Pharmabarometer-August-2022-neuer-Titel-2-scaled-1-300x223.jpg 300w, https:\/\/value-dossier.com\/wp-content\/uploads\/2022\/08\/Pharmabarometer-August-2022-neuer-Titel-2-scaled-1-1024x760.jpg 1024w, https:\/\/value-dossier.com\/wp-content\/uploads\/2022\/08\/Pharmabarometer-August-2022-neuer-Titel-2-scaled-1-768x570.jpg 768w, https:\/\/value-dossier.com\/wp-content\/uploads\/2022\/08\/Pharmabarometer-August-2022-neuer-Titel-2-scaled-1-1536x1141.jpg 1536w, https:\/\/value-dossier.com\/wp-content\/uploads\/2022\/08\/Pharmabarometer-August-2022-neuer-Titel-2-scaled-1-2048x1521.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><p id=\"caption-attachment-6026\" class=\"wp-caption-text\">Figure: Price decrease after negotiations for drugs that underwent AMNOG benefit assessments between 2011 \u2013 2022. The price loss is shown as percent difference between the launch price and the final reimbursement price. Prices after deduction of taxes and mandatory rebates were used for the calculation. Boxes indicate the 25th and 75th percentile, the median is marked by the horizontal line, and the mean by X. The mean values are labelled. Source: Lauertaxe, August 2022; www.g-ba.de 2022.<\/p><\/div>\n        <\/div>\n\n    <\/div>\n<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[91],"tags":[],"class_list":["post-7026","post","type-post","status-publish","format-standard","hentry","category-amnog-reimbursement-amount-negotiations"],"acf":[],"_links":{"self":[{"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/posts\/7026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/comments?post=7026"}],"version-history":[{"count":1,"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/posts\/7026\/revisions"}],"predecessor-version":[{"id":7027,"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/posts\/7026\/revisions\/7027"}],"wp:attachment":[{"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/media?parent=7026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/categories?post=7026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/value-dossier.com\/en\/wp-json\/wp\/v2\/tags?post=7026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}